Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization-Reference-Cited by-同舟云学术

Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization

Published:2016-02-18 Issue:5 Volume:5 Page:e1143995
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Fan,Yang Junlan,Li Huafei,Liu Moyan,Zhang Jie,Zhao Lichao,Wang Lingxiong,LingHu RuiXia,Feng Fan,Gao Xudong,Dong Biqin,Liu Xiaohan,Zi Jian,Zhang Weijing,Hu Yi,Pan Jingkun,Tian Lei,Hu Yazuo,Han Zhitao,Zhang Honghong,Wang Xiaoning,Zhao Lei

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1143995

Reference43 articles.

1. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

2. Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

3. Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels

4. Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy

5. Acquired Resistance to Rituximab Is Associated with Chemotherapy Resistance Resulting from Decreased Bax and Bak Expression

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma;Cancer Immunology, Immunotherapy;2022-12-19

2. CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma;2022-08-25

3. GENOME-WIDE METHYLOME ANALYSIS USING METHYLCAP-SEQ UNCOVERS NOVEL METHYLATED MARKERS FOR CANINE LYMPHOMA CELL LINE CLBL-1;Taiwan Veterinary Journal;2019-07-22

4. Quantifying The Adhesion Forces of Lymphoma Cells by AFM Single-cell Force Spectroscopy;PROG BIOCHEM BIOPHYS;2019

5. MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells;OncoTargets and Therapy;2018-11